KRAS acting through ERK signaling stabilizes PD-L1 via inhibiting autophagy pathway in intrahepatic cholangiocarcinomaZheng Gao(Ministry of Education of the People's Republic of China), Zhen‐Bin Ding(Fudan University)Cancer Cell InternationalMarch 19, 202210.1186/s12935-022-02550-wCited by 33SaveCiteExport RISWatch citationsRelated PapersStromal architecture and fibroblast subpopulations with opposing effects on outcomes in hepatocellular carcinoma|Cell Discovery|2025|48SQSTM1/p62 in Intrahepatic Cholangiocarcinoma Promotes Tumor Progression Via Epithelial-Mesenchymal Transition and Mitochondrial Function Maintenance|Research Square|2021|1